Sirio Unveils Tailored Women's Wellness Platform at Vitafoods Europe

India Pharma Outlook Team | Friday, 29 March 2024

 women’s health, clinical studies,  India Pharma Outlook

Sirio Pharma, the global nutraceutical contract development and manufacturing organization (CDMO) headquartered in Europe, will launch a women’s health platform that includes hormone health, women’s wellness, and menopause segments at Vitafoods Europe. The new 25-formulation-strong portfolio is customized for multiple health considerations and different life stages, with products covering periods beginning with puberty and petering out at menopause.

Sirios leveraged its global R'n'D competencies to present a first-on-shelf and premium product portfolio backed by branded uniforms, consumer trends, clinical data and stability studies.

The new direction of women’s health, which relies on age modulation, is the defining trend in 2024. The early research on this was also undertaken to incorporate options concerning complex formulation science and segmenting production types. This means more or less that we have done the whole job, and the good news to our brand partners is that they can easily jump to launching their products to the public at first. “said Ms. Sara Lesina, Sirio Europe & Americas General Manager.

Three of the products on display at Vitafoods Europe between May 14-16, 2024, in Geneva will be included. Thankfully, it is not just a standard gummy that utilizes “MenoBalance” proprietary ingredients meant for those who plan to reach or have already reached menopause and contain Novasoy. This FDA-approved soy isoflavone has yet to be used in a gummy. On this note, research indicates that soy isoflavones lower the hot flash severity and frequency. Moreover, they almost always help to form healthy bones after menopause.

This groundbreaking formula is a phenomenon because, in the history of Novalok, science-based ingredients had not been introduced before as gummies. This promotes wellness, enriching every bite with amazing taste. Paula Limena, VP of global marketing – health & wellness at ADM, comments: “We are pretty set to join forces with Sirio, who is skillful in gummy making, and we look forward to their support. This collaboration brings the best of both worlds and allows us to build novel concepts that are not only tasty but also nutritious.”

ADM has long been an industry pioneer in providing the highest quality human nutrition with more than 50 pre-clinical and human clinical studies. This has resulted in the development of individualized and customized nutritional offerings being marketed to discover new avenues for wellness for the consumer of tomorrow.

© 2024 India Pharma Outlook. All Rights Reserved.